Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
A sortable and searchable running inventory of global medtech regulatory and policy official documents, including rules, guidance documents, memos, white papers, and more from national authorities, non-governmental groups, and global organizations.
Low back pain, one of the most prevalent chronic conditions, is in the early stages of moving toward a more stratified, personalized model of care. Large spine companies remain focused on their core, one-size-fits-all businesses, while advances in scientific understanding of pain and technology are creating opportunities for new entrants like Aclarion, Persica Pharma, and Boston Scientific. A first of its kind, the NIH Heal Initiative has laid the groundwork, even as it weathers funding cuts
FDA’s new Quality Management System Regulation takes effect. Excerpted from Pathways’ Pick of the Week March 4: FDA Adopts QMSR, EU Harmonizes Standards, South Korea Spotlights Innovation.